The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–250 of 250
Co-localization of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey cerebellum
Pardue, S., Rapoport, S. I., & Bosetti, F. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00262-6 · Cited by 45
Lu, X., Ong, W.-Y., Halliwell, B. B., Horrocks, L. A., & Farooqui, A. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00528-7 · Cited by 44
Self-citationKanfer, J. N., Sorrentino, G., & SITAR, D. S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00806-4 · Cited by 43
Characterization of a Novel Phospholipase A2 Activity in Human Brain
Ross, B. M., Kim, D. K., Bonventre, J. V., & Kish, S. J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052213.x · Cited by 43
Secretory phospholipase A2-mediated neuronal cell death involves glutamate ionotropic receptors
Kolko, M., de Turco, E. B. R., Diemer, N. H., et al. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00026 · Cited by 43
Ong, W., Ren, M., Makjanić, J., Lim, T., & Watt, F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721574.x · Cited by 43
Self-citationBasselin, M., Chang, L., Seemann, R., Bell, J. M., & Rapoport, S. I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01811.x · Cited by 42
Anderle, P., Farmer, P. J., Berger, A., & Roberts, M.-A. (2003) · Nutrition · doi:10.1016/j.nut.2003.09.018 · Cited by 42
Ong, W., Hu, C. Y., Hjelle, O. P., Ottersen, O. P., & Halliwell, B. B. (2000) · Experimental Brain Research · doi:10.1007/s002210000347 · Cited by 42
Self-citationMandal, P. K., & Pettegrew, J. W. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000013750.80925.25 · Cited by 42
OBATA, T., SAKURAI, Y., Kase, Y., et al. (2003) · Journal of Chromatography B · doi:10.1016/s1570-0232(03)00311-8 · Cited by 41
St-Gelais, F., Ménard, C., Congar, P., Trudeau, L., & Massicotte, G. (2004) · Hippocampus · doi:10.1002/hipo.10176 · Cited by 39
BanI Polymorphism of the Cytosolic Phospholipase A2 Gene and Mood Disorders in the Korean Population
Pae, C., Yu, H.-S., Kim, J.-J., Lee, C., Lee, S.-J., Lee, K., Jun, T., Paik, I., Serretti, A., & Lee, C. (2004) · Neuropsychobiology · doi:10.1159/000077364 · Cited by 38
Horrocks, L. A., Demediuk, P., Saunders, R. D., Dugan, L. L., Clendenon, N. R., Means, E. D., & Anderson, D. K. (1985) · Central Nervous System Trauma · doi:10.1089/cns.1985.2.115 · Cited by 37
Self-citationNew weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase
Miele, L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17506 · Cited by 37
RYBAKOWSKI, J. K., Borkowska, A., Czerski, P. M., Dmitrzak‐Węglarz, M., & Hauser, J. (2003) · Neuropsychobiology · doi:10.1159/000070578 · Cited by 37
Blockade of long-term depression in neonatal hippocampal slices by a phospholipase A2 inhibitor
Fitzpatrick, J. S., & Baudry, M. (1994) · Developmental Brain Research · doi:10.1016/0165-3806(94)90012-4 · Cited by 37
Molecular targets of lithium action
Corbella, B., & Vieta, E. (2003) · Acta Neuropsychiatrica · doi:10.1046/j.1601-5215.2003.00049.x · Cited by 36
Peroxisomal Disorders and Regulation of Genes
(2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3 · Cited by 34
Qu, Y., Chang, L., Klaff, J., Seemann, R., & Rapoport, S. I. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300177 · Cited by 33
Arachidonic Acid, Neurotrauma, and Neurodegenerative Diseases
Farooqui, A. A., Rosenberger, T. A., & Horrocks, L. A. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2582-7_13 · Cited by 32
Self-citationCa2+-Independent Phospholipase A2 Inhibiror Impairs Spatial Memory of Mice.
Fujita, S., Ikegaya, Y., Nishiyama, N., & Matsuki, N. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.83.277 · Cited by 32
Salvati, S., Natali, F., Attorri, L., Raggi, C., Biase, A. D., & Sanchez, M. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00172-4 · Cited by 30
Quinacrine acts as an antioxidant and reduces the toxicity of the prion peptide PrP106-126
Turnbull, S., Tabner, B. J., Brown, D. R., & Allsop, D. (2003) · Neuroreport · doi:10.1097/00001756-200309150-00017 · Cited by 30
Potential therapeutic uses of phospholipase A2inhibitors
Clark, J. D., & Tam, S. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.7.937 · Cited by 29
Yoo, M.-H., Woo, C.-H., You, H. J., Cho, S.-H., Byung-Chul, K. I. M., Choi, J. E., Chun, J. S., Jhun, B. H., Kim, T. S., & Kim, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101975200 · Cited by 29
Ontogeny of cytosolic phospholipase A2 activity in rat brain
Yoshihara, Y., Yamaji, M., Kawasaki, M., & Watanabe, Y. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80992-1 · Cited by 29
Secreted phospholipase A 2 enzymes as therapeutic targets
Scott, K. F., Graham, G. G., & Bryant, K. J. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.3.427 · Cited by 29
Farooqui, A. A., Ong, W., & Horrocks, L. A. (2004) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1568006043481239 · Cited by 29
Self-citationCytosolic phospholipase A2 and the distinct transcriptional programs of astrocytoma cells
Hernández, M., Nieto, M. L., & Crespo, M. S. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01563-0 · Cited by 28
Vanags, D. M., Larsson, P., Feltenmark, S., Jakobsson, P., Orrenius, S., Claesson, H., & Aguilar‐Santelises, M. (1997) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400269 · Cited by 28
Kramer, B. C., Yabut, J. A., Cheong, J., JnoBaptiste, R., Robakis, T. K., Olanow, C. W., & Mytilineou, C. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03111.x · Cited by 27
Annexins: Novel Ca2+-Dependent Regulators of Membrane Function
Kaetzel, M. A., & Dedman, J. (1995) · Physiology · doi:10.1152/physiologyonline.1995.10.4.171 · Cited by 26
Regulation of group VIA phospholipase A2 expression by sterol availability
Seashols‐Williams, S. J., Olivares, A. D. C., Gil, G., & Barbour, S. E. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.05.003 · Cited by 25
Yoshinaga, N., Yasuda, Y., Murayama, T., & Nomura, Y. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02340-9 · Cited by 25
KUROIWA, N., Nakamura, M., Tagaya, M., & Takatsuki, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4381 · Cited by 20
Chronic cocaine administration reduces phospholipase A2 activity in rat brain striatum
Ross, B. M., & Turenne, S. D. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0385 · Cited by 20
Huterer, S. J., Tourtellotte, W. W., & Wherrett, J. R. (1995) · Neurochemical Research · doi:10.1007/bf00992509 · Cited by 19
Tong, W., Shah, D., Xu, J., Diehl, J. A., Hans, A., Hannink, M., & Sun, G. Y. (1999) · Journal of Molecular Neuroscience · doi:10.1007/bf02736923 · Cited by 19
Bate, C., & Williams, A. (2004) · Journal of General Virology · doi:10.1099/vir.0.80366-0 · Cited by 18
Qu, Y., Chang, L., Klaff, J., Seemann, R., Balbo, A., & Rapoport, S. I. (2003) · Brain Research Protocols · doi:10.1016/s1385-299x(03)00057-6 · Cited by 16
Cytosolic Phospholipase A2 Inhibitors as Therapeutic Agents for Neural Cell Injury
Farooqui, A. A., Wei-YiOng, B. S. P., Lü, X., et al. (2002) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1568014023355917 · Cited by 15
Self-citationYagi, K., Shirai, Y., Hirai, M., Sakai, N., & Saito, N. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.12.006 · Cited by 14
Ong, W., Ling, S.-F., Yeo, J.-F., Chiueh, C. C., & Farooqui, A. A. (2005) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:2005051 · Cited by 13
Self-citationEffects of impact injury of rat spinal cord on activities of some enzymes of lipid hydrolysis
Taylor, W. A. (1988) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 13
Burgermeister, E., Tibes, U., Stockinger, H., & Scheuer, W. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00011-4 · Cited by 12
Phospholipids and Signal Transmission
Massarelli, R., Horrocks, L. A., Kanfer, J. N., & Löffelholz, K. (1993) · Springer eBooks · doi:10.1007/978-3-662-02922-0 · Cited by 11
Self-citationDisorders of synaptic plasticity and schizophrenia
Smythies, J. (2004) · Cited by 8
Laktionov, P. P., RYKOVA, E. Y., Toni, M., Spisni, E., Griffoni, C., Bryksin, A. V., Volodko, N. V., Vlassov, V. V., & Tomasi, V. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.10.012 · Cited by 4
Plasmalogens, platelet-activating factor, and other ether glycerophospholipids
Farooqui, A. A., & Horrocks, L. A. (2012) · Elsevier eBooks · doi:10.1533/9780857097934.107 · Cited by 4
Self-citation
Cited by
A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression
Lin, P.-Y., Huang, S.-Y., & Su, K.-P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.018 · Cited by 530
Biochemistry and Physiology of Mammalian Secreted Phospholipases A2
Lambeau, G., & Gelb, M. H. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.062405.154007 · Cited by 513
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Modulation of inflammation in brain: A matter of fat
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04371.x · Cited by 460
Self-citationLayé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
Metadata
- Authors
- Farooqui, A. A., Ong, W.-Y., & Horrocks, L. A.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 58
- Issue
- 3
- Pages
- 591-620
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2130109770
- Cited by
- 368
- References
- 250
- FWCI
- 25.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.